Safety, Tolerability, and Pharmacokinetics of IRL201104 in Healthy Volunteers
Clinical trial NCT05921591 · COMPLETED
Trial details
- NCT number
- NCT05921591
- Sponsor
- Revolo Biotherapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-26
- Primary completion
- 2023-09-12
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.